European Commission approves Dupixent for severe atopic dermatitis in children aged 6-11 years Nov. 30, 2020 No Comments
InMed reports results from an initial phase I trial of INM-755 healthy subjects Nov. 26, 2020 No Comments
Positive topline data from phase IIb study of ARQ-154 in scalp and body psoriasis Nov. 24, 2020 No Comments
Tofacitinib demonstrates long-term safety and efficacy in refractory dermatomyositis Nov. 17, 2020 No Comments
Phase III trial shows efficacy and safety of intravenous immunoglobulin in treating dermatomyositis Nov. 17, 2020 No Comments
Designed Cells, Chungbuk National University patent stem cell-derived exosome-rich culture medium Nov. 17, 2020 No Comments
RSS